🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

E-Cigarette users were less likely to undergo lung cancer screening. E-Cigarette Use and Lung Cancer Screening Uptake jamanetwork.com/journals/jaman…

Under age 50 when diagnosed with lung cancer? Researchers want to know why. Participate in a new study on risk factors in younger adults and help researchers crack the code on a young lung cancer diagnosis.  bit.ly/41rqHE0

🧬 Using a model that integrates clinical, dual-energy spectral CT, and radiomics features may “enhance the prediction” of mutated KRAS in patients with lung adenocarcinoma, according to a recent study. ➡️ Learn more: buff.ly/3CjnKLT #KRAS #NSCLC #LungCancer #lcsm

𝐒𝐮𝐫𝐯𝐢𝐯𝐨𝐫 𝐠𝐮𝐢𝐥𝐭: A hidden burden of #LungCancer survivorship. In our latest blog, we explore what survivor guilt is, how it impacts lung cancer survivors, & ways to cope. You’re not alone, & support is always available. 🩵 go2.org/blog/ask-the-e…

Our study in JAMA found that most people eligible for #lungcancerscreening (LCS) are already getting screened for breast & colon cancers. LCS eligible adults ARE receptive to cancer screening. They are NOT “hard to reach,” they are “hardly reached.”

Our team is so grateful to have been able to attend an event honoring Tylee Craft (Tylee Craft ), winner of the Eric Montross Award for Public Service at UNC-Chapel Hill. Tylee was posthumously honored for his commitment to increasing awareness of #lungcancer and low rates of

We must talk about pneumonitis in #lungcancer treatment! Resistance is horrible, but you understand the reasoning behind stopping treatment. When a treatment is working and has to be stopped due to pneumonitis, it sidelines patients & eliminates many future options - It is cruel

Reduced smoking = fewer cancer deaths. From 1970–2022, reductions in smoking accounted for 51.4% of of the drop in overall lung cancer mortality. Declines in cancer deaths were greater in men (60.1%) than in women (42.7%). acsjournals.onlinelibrary.wiley.com/doi/full/10.33… OncoAlert Farhad Islami, MD PhD

🗓️ Lung cancer leaders—save the date! The Centers of Excellence Summit & Navigator Workshop returns Oct 9–11 in Denver! Theme: Strength & Unity: Empowering Community Early-bird reg is OPEN! Join the experts driving innovation in #LungCancer care: go2.org/coe-summit?utm…

There is a lot of exciting research at #AACR25, but don't forget -- patients only benefit from new therapies if they can stay on and tolerate them! I'm honored and excited to give two talks, both bridging the gap between science and the lived experience: 1. April 28th, Major

Why does it take years for a cancer drug to be approved by the FDA? From discovery to post-market surveillance, the process is long, but critical. GO2’s Precision Medicine & Navigation Manager, Matthew Reiss, MSE, PhD, breaks it down in our latest blog: tinyurl.com/4p87pp67

If we aren’t measuring what matters, we aren’t just missing data - we are missing the point! #AACR25 #LCSM

Lay navigators improve lung cancer screening rates! The Thoracic Surgery Foundation (TSF) The Society of Thoracic Surgeons STS Advocacy AATS GO2 for Lung Cancer ACS National Lung Cancer Roundtable Alliance for Patient Access LUNGevity Foundation Kaiser Permanente Bernard J. Tyson School of Med LungCancerAmerica American Thoracic Society (ATS) American Cancer Society American Cancer Society Cancer Action Network

Attendees in last month’s Biomarker Summit took bold steps in creating more lung cancer survivors. The day-long workshop asked participants to come together - developing and prioritizing projects that will shape the roundtable’s 2026 biomarker workplan.

New from the #JACR 📝 For decades, a key mechanism to ensure quality management in radiology practices has been American College of Radiology accreditation. However, no such program currently exists for AI in radiology - and that is something the ACR Commissions on Quality and Safety and

Meaningful change looks like this! The Indy 500 Parade, Indiana’s 1st Mobile Lung Screening Unit rolled past 200K+ spectators-delivering facts & urgent awareness. View & Listen to the 40 sec PSA.Proud to work with #EndLungCancerNow #screeningsaveslives #keepgoing IU Simon Comprehensive Cancer Center

Before and After. Just 8 weeks. Nope, not lymphoma. THIS is non-small cell lung cancer. THIS is why molecular profiling matters. THIS is why targeted therapy changes lives.

🚨 #Lungcancer survival has more than doubled. New real-world data from France shows 3-year survival for lung adenocarcinoma rose from 16.3% (2000) to 38.6% (2020) driven by earlier diagnosis & targeted treatment. This is what progress looks like. But it must reach everyone who

Check out this exciting new study led by Matthew Smeltzer Raymond Osarogiagbon, MBBS, FACP in JAMA Network Open!! Changing the USPSTF lung screening criteria from a 20-pack-year cutoff to a 20-year duration cutoff (Potter Criteria) greatly increases access to screening while maintaining screening